Calendar

Cloudflare's high recent revenue growth and history of beating consensus make the business momentum worth monitoring, but the stock fell sharply into the event on rising volume, with a major late-week software-sector decline; checked sources did not show positive estimate revisions or revenue upside.

Earnings Whispers lists a $2.94 whisper against $2.89 consensus EPS, a modest positive indication, while the available revenue figure is consensus rather than demonstrated upside. Current pre-event price/volume evidence was not verified, so required tape confirmation is absent and the score remains below threshold.

Earnings Whispers confirms the November 5 date and gives $0.30 EPS consensus and $2.48B revenue estimate, but shows no positive whisper and no verified estimate revisions or revenue upside. Recent tape data was not established; strong weekly XLP performance is supportive sector context but does not satisfy the missing stock-level signals.

EOG’s shares rose about 1.5% over five sessions and closed near the top of the Oct. 30 range, while the latest company results described record second-quarter performance and low net debt-to-capitalization. But the checked sources did not establish positive EPS revisions/ESP/whisper or a positive revenue revision, and recent volume was not unusually high. These mixed inputs do not support a qualifying pre-earnings surprise setup.

AI/cloud optical demand and management’s Q1 revenue outlook support strong business momentum, while the shares retained positive five-session strength and showed a high-close session. However, the current consensus revenue estimate slightly exceeds the midpoint of company guidance, no positive EPS revision/ESP was verified, and the latest high-volume decline coincided with reported acquisition-talk volatility; required surprise signals are therefore incomplete.

SPG showed a firm pre-event tape and improving reported property operating metrics, but the checked sources did not establish positive current-quarter estimate revisions or a revenue-upside signal; Oct. 30 turnover was below the required 1.5x threshold. This is not a qualifying surprise setup.

Natera's Q2 release showed a 21.2% increase in reported tests and raised 2026 revenue outlook, supporting business momentum; its stock was up over the five sessions through Oct 30 and had a strong Oct 29 close. But checked estimate sources disagree on consensus revenue/EPS and did not establish positive estimate revisions or a positive whisper gap, while the largest recent volume spike came on a sharp down day. These gaps keep it below the screen threshold.

Devon entered the final October session with a positive five-session trend and a strong Oct. 30 close location, but the checked sources supplied EPS and revenue consensus without evidence of upward estimate revisions or a revenue-upside signal; the required surprise indicators remain unproven.

TEAM has a positive reported whisper gap and three-month upward estimate revisions, alongside strong cloud and RPO growth in its latest filed quarter. However, the stock fell sharply into the event, closed below the required close-location threshold in each of the last three sessions, and the high-volume sessions were selloffs rather than accumulation; the required tape setup is absent.

Con Edison officially scheduled Q3 results for Nov 5, and checked sources provide an EPS consensus, but the required positive EPS revision/whisper and revenue consensus or upside evidence were not verified. The stock recovered over the final two sessions with an Oct 30 close near the lower-middle of its daily range; the available tape alone is insufficient for a qualifying surprise setup.

Analyst estimates have risen over three months and Microchip previously described improving demand and inventory normalization, but the latest session was a high-volume decline and semiconductors sold off sharply; the tape and sector risk overwhelm the improving estimates for this pre-event setup.

Recent revenue growth and an improving late-week share price are constructive, but the available estimate-change data show a substantial EPS downgrade trend, volume never confirms accumulation, and ongoing antitrust litigation adds material uncertainty.

Arm's upcoming-quarter EPS estimate had moved higher over the prior month and the company's prior guidance cited strong AI-related demand, but the current tape fell sharply into the event, the sector was weak, and no positive revenue revision/upside beyond consensus was verified. The official event is Nov. 4, not the supplied Nov. 5 date; both fall within the screen window.

MRNA rebounded about 10.8% over the five sessions through Oct. 30, and the Oct. 29 close-location reading was above 0.75. However, the checked sources show no positive EPS-revision/ESP/whisper or revenue-upside signal, while the sharp Oct. 22 selloff tied to prematurely published melanoma-vaccine results leaves event-driven volatility elevated. The reported consensus is still loss-making, so the price rebound alone is not enough for a qualifying surprise setup.

Brookfield's second-quarter transcript described record fundraising and growth in fee-bearing capital, while available third-party estimates indicate positive expected year-over-year EPS and revenue growth. However, current-fiscal-year consensus EPS had declined slightly over 90 days, no qualifying volume expansion was verified, and the checked data do not confirm a positive pre-event revision signal.

HUM's recent tape is weak despite a close near the high on Oct 29, and the quarter consensus calls for a loss with EPS estimates recently moving down. Revenue is expected to rise year over year, but no positive revenue revision/upside signal was verified; Medicare Advantage margin, star-rating and cost pressures leave little evidence of a near-term surprise setup.

Vistra’s checked estimate page shows modest positive one-month EPS revisions but revenue estimates down 6.46% over one month and 10.52% over three months; the October 30 close remained below October 23 and the recent tape lacks a verified qualifying close location, so the setup does not meet required signals.

Is Tesla Earnings Miss and Negative Free Cash Flow a Red Flag for Rivian and Lucid Investors ?